RU2000100062A - METHOD OF OBTAINING 14-HYDROXYNORMORPHINONES AND OXYCODON, NOROXYMORPHONE AND NALTREXONE FROM NORMORPHINONES - Google Patents
METHOD OF OBTAINING 14-HYDROXYNORMORPHINONES AND OXYCODON, NOROXYMORPHONE AND NALTREXONE FROM NORMORPHINONESInfo
- Publication number
- RU2000100062A RU2000100062A RU2000100062/04A RU2000100062A RU2000100062A RU 2000100062 A RU2000100062 A RU 2000100062A RU 2000100062/04 A RU2000100062/04 A RU 2000100062/04A RU 2000100062 A RU2000100062 A RU 2000100062A RU 2000100062 A RU2000100062 A RU 2000100062A
- Authority
- RU
- Russia
- Prior art keywords
- group
- carbon atoms
- formula
- lower alkyl
- alkyl
- Prior art date
Links
- DQCKKXVULJGBQN-XFWGSAIBSA-N Naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 title 1
- 229960003086 Naltrexone Drugs 0.000 title 1
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycontin Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title 1
- HLMSIZPQBSYUNL-IPOQPSJVSA-N noroxymorphone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4 HLMSIZPQBSYUNL-IPOQPSJVSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 38
- 125000004432 carbon atoms Chemical group C* 0.000 claims 26
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 20
- 125000005265 dialkylamine group Chemical group 0.000 claims 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 239000001257 hydrogen Substances 0.000 claims 12
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 12
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- 239000002253 acid Substances 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 239000002904 solvent Substances 0.000 claims 7
- 239000003153 chemical reaction reagent Substances 0.000 claims 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims 6
- 239000007800 oxidant agent Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- -1 dienol acetates Chemical class 0.000 claims 4
- 235000019253 formic acid Nutrition 0.000 claims 4
- NFDFQCUYFHCNBW-SCGPFSFSSA-N Dienestrol Chemical compound C=1C=C(O)C=CC=1\C(=C/C)\C(=C\C)\C1=CC=C(O)C=C1 NFDFQCUYFHCNBW-SCGPFSFSSA-N 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 3
- WNWVKZTYMQWFHE-UHFFFAOYSA-N 4-ethylmorpholine Chemical group [CH2]CN1CCOCC1 WNWVKZTYMQWFHE-UHFFFAOYSA-N 0.000 claims 2
- MLVMHYBEWQXNNS-OEUJKCCCSA-N C(C)(=O)C1(CC=C2C[C@@H]3[C@@H]4C=CC([C@H]5[C@@]4(C2=C1O5)CCN3C)=O)O Chemical compound C(C)(=O)C1(CC=C2C[C@@H]3[C@@H]4C=CC([C@H]5[C@@]4(C2=C1O5)CCN3C)=O)O MLVMHYBEWQXNNS-OEUJKCCCSA-N 0.000 claims 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N Meta-Chloroperoxybenzoic acid Chemical group OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims 2
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 2
- JJGRKZBXASWTLH-JFJMRBLZSA-N C(C1=CC=CC=C1)C1(CC=C2C[C@@H]3[C@@H]4C=CC([C@H]5[C@@]4(C2=C1O5)CCN3C)=O)O Chemical compound C(C1=CC=CC=C1)C1(CC=C2C[C@@H]3[C@@H]4C=CC([C@H]5[C@@]4(C2=C1O5)CCN3C)=O)O JJGRKZBXASWTLH-JFJMRBLZSA-N 0.000 claims 1
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 0 CCC(C(C)C1)(C(C(Cc2ccc3O*)N*)[C@@]1([C@@]1C)c2c3O)C=C1OC(*)O Chemical compound CCC(C(C)C1)(C(C(Cc2ccc3O*)N*)[C@@]1([C@@]1C)c2c3O)C=C1OC(*)O 0.000 description 2
Claims (25)
включающий взаимодействие норморфинон диенол ацетатов формулы
где R выбирают из группы, состоящей из низшего алкила с 1-7 атомами углерода, циклоалкилметила с 3-6 кольцевыми атомами углерода, и замещенного и незамещенного бензила формулы
где Q и Q' раздельно выбирают из группы, состоящей из водорода, нижнего алкила, трифторметила, нитро, диалкиламина или циана,
R' выбирают из группы, состоящей из R, 2-(4-морфолинил)этила,
R''С(О)-, и бензилоксикарбонила, где R'' - низший алкил с 1-4 атомами углерода; с окисляющим средством при температуре от, примерно 15oС до примерно 70oC в присутствии слабой кислоты и водного, или водного и органического растворителя для растворения указанных реагентов в течение времени, достаточного для образования 14-гидроксинорморфинонов.1. The method of obtaining 14-hydroxynormorphinones of the formula
including interaction normorphinone dienol acetates of the formula
where R is selected from the group consisting of lower alkyl with 1-7 carbon atoms, cycloalkylmethyl with 3-6 ring carbon atoms, and substituted and unsubstituted benzyl of the formula
where Q and Q 'are separately selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine or cyan,
R 'is selected from the group consisting of R, 2- (4-morpholinyl) ethyl,
R''C (O) -, and benzyloxycarbonyl, where R "is lower alkyl with 1-4 carbon atoms; with an oxidizing agent at a temperature of from about 15 ° C to about 70 ° C in the presence of a weak acid and an aqueous, or aqueous and organic solvent to dissolve these reagents for a time sufficient to form 14-hydroxy-normorphinones.
включающий взаимодействие норморфинонов формулы
где R выбирают из группы, состоящей из низшего алкила с 1-7 атомами углерода, циклоалкил - низшего алкила с 3-6 кольцевыми атомами углерода, бензила и замещенного - бензила формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина и циана, R' выбирают из группы, состоящей из R, 2-(4-морфолинил)этила, бензилокси карбонила и R''C(O)-, где R'' - низший алкил с 1-4 атомами углерода, с перекисью водорода при температуре от, примерно 15oС до около 70oС в присутствии кислоты и водосодержащего растворителя для растворения указанного реагента в течение времени, достаточного для образования 14-гидроксинорморфинонов.5. The method of obtaining 14-hydroxynormorphinones of the general formula
including the interaction of normorphinones of the formula
where R is selected from the group consisting of lower alkyl with 1-7 carbon atoms, cycloalkyl - lower alkyl with 3-6 ring carbon atoms, benzyl and substituted - benzyl of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine and cyan, R' is selected from the group consisting of R, 2- (4-morpholinyl) ethyl, benzyloxy carbonyl and R " C (O) -, where R "is lower alkyl with 1-4 carbon atoms, with hydrogen peroxide at a temperature of from about 15 ° C to about 70 ° C in the presence of an acid and a water-based solvent to dissolve the specified reagent over time, sufficient to form 14-hydroxinormorphinones.
где R' выбирают из группы, состоящей из замещенной и незамещенной бензиловых групп формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина и циана, и R выбирают из группы, состоящей из R', и циклоалкил - низшего алкила с 3-6 кольцевыми атомами углерода формулы
где R' выбирают из группы, состоящей из алкила с 1-7 атомами углерода и замещенного и незамещенного бензила формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина, циана, и R' - алкил с от 1 до 4 атомами углерода
(В)
где R выбирают из группы, состоящей из алкила с 1-7 атомами углерода, циклоалкил - низшего алкил с 3-6 кольцевыми атомами углерода и замещенного и незамещенного бензила формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина, циана, R' выбирают из группы, состоящей из замещенного и незамещенного бензила, как определено выше, и R''C(O)- где R'' - алкил с 1-4 атомами углерода, и при условиях, что (1) оба R и R' не могут одновременно быть метилом, (2) когда R - метил, то R' не может быть бензилом, и (3) когда R' - метил, то R не может быть циклопропилметилом;
(Г)
где R выбирают из группы, состоящей из алкила с 1-7 атомами углерода, циклоалкил - низшего алкила с 3-6 кольцевыми атомами углерода и замещенного и незамещенного бензила формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина, циана, R' выбирают из группы, состоящей из R и R''C(O)-, где R'' - алкил с 1-4 атомами углерода, при условии, что R, R' и R'' не являются, все одновременно низшим алкилом, и
(Д)
где R - выбирают из группы, состоящей из незамещенного бензила формулы
где Q и Q' раздельно выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина, циана и циклоалкил - низшего алкила с 3-6 кольцевыми атомами углерода, и R' - замещенный и незамещенный бензил, как определено выше, в качестве промежуточного продукта.14. Normorphin, normorphinone and normorphinone dienol acylate compounds are selected from the group consisting of formula (I)
where R 'is selected from the group consisting of substituted and unsubstituted benzyl groups of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine and cyan, and R is selected from the group consisting of R', and cycloalkyl is lower alkyl with 3-6 ring carbon atoms of the formula
where R 'is selected from the group consisting of alkyl with 1-7 carbon atoms and substituted and unsubstituted benzyl of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine, cyan, and R' is alkyl with from 1 to 4 carbon atoms
(AT)
where R is selected from the group consisting of alkyl with 1-7 carbon atoms, cycloalkyl is lower alkyl with 3-6 ring carbon atoms and substituted and unsubstituted benzyl of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine, cyan, R' is selected from the group consisting of substituted and unsubstituted benzyl, as defined above, and R''C (O) - where R "is alkyl with 1-4 carbon atoms, and under the conditions that (1) both R and R 'cannot simultaneously be methyl, (2) when R is methyl, then R' cannot be benzyl, and (3) when R 'is methyl, then R cannot be cyclopropylmethyl;
(Y)
where R is selected from the group consisting of alkyl with 1-7 carbon atoms, cycloalkyl - lower alkyl with 3-6 ring carbon atoms and substituted and unsubstituted benzyl of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine, cyan, R' is selected from the group consisting of R and R "C (O) -, where R" is alkyl with 1-4 carbon atoms, provided that R, R 'and R "are not, all at the same time lower alkyl, and
(D)
where R is selected from the group consisting of unsubstituted benzyl of the formula
where Q and Q 'are separately selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine, cyan and cycloalkyl - lower alkyl with 3-6 ring carbon atoms, and R' is substituted and unsubstituted benzyl, as defined above, as an intermediate product.
где R' выбирают из группы, состоящей из замещенного и незамещенного бензила формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина, циана, и R выбирают из группы, состоящей из R' и циклоалкил - низшего алкила с 3-6 кольцевыми атомами углерода.15. The compound of claim 14 of formula (I)
where R 'is selected from the group consisting of substituted and unsubstituted benzyl of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine, cyan, and R is selected from the group consisting of R' and cycloalkyl - lower alkyl with 3-6 ring carbon atoms.
где R' выбирают из группы, состоящей из алкила с 1-7 атомами углерода и замещенного бензила формулы
где Q и Q' раздельно выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина, циана, и R'' - алкил с 1-4 атомами углерода.16. The compound of claim 14 of formula (II)
where R 'is selected from the group consisting of alkyl with 1-7 carbon atoms and substituted benzyl of the formula
where Q and Q 'are separately selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine, cyan, and R "- alkyl with 1-4 carbon atoms.
где R выбирают из группы, состоящей из алкила с 1-7 атомами углерода, циклоалкил - низшего алкила с 3-6 кольцевыми атомами углерода и замещенного и незамещенного бензила формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина и циана, R' выбирают из группы, состоящей из R''C(O)-, где R'' - алкил с 1-4 атомами углерода и, при условиях, что
(1) оба R и R' не могут быть одновременно метилом,
(2) когда R - метил, то R'' не может быть бензилом,
(3) когда R' - метил, то R не может быть циклопропилметилом.17. The compound of claim 14 of formula (III)
where R is selected from the group consisting of alkyl with 1-7 carbon atoms, cycloalkyl - lower alkyl with 3-6 ring carbon atoms and substituted and unsubstituted benzyl of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine and cyan, R' is selected from the group consisting of R "C (O) -, where R" is alkyl with 1 -4 carbon atoms and, under the conditions that
(1) both R and R 'cannot be methyl at the same time,
(2) when R is methyl, then R "cannot be benzyl,
(3) when R 'is methyl, then R cannot be cyclopropylmethyl.
где R выбирают из группы, состоящей из алкила с 1-7 атомами углерода, циклоалкил - низшего алкила с 3-6 кольцевыми атомами углерода и замещенного и незамещенного бензила формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина и циана, R' выбирают из группы, состоящей из R и R''C(O)-, где R'' - алкил с 1-4 атомами углерода, при условии, что R, R' и R'' - не могут быть все одновременно низшим алкилом.18. The compound of claim 14 of formula (IV)
where R is selected from the group consisting of alkyl with 1-7 carbon atoms, cycloalkyl - lower alkyl with 3-6 ring carbon atoms and substituted and unsubstituted benzyl of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine and cyan, R' is selected from the group consisting of R and R "C (O) -, where R" is alkyl with 1-4 carbon atoms, provided that R, R 'and R "- cannot all be simultaneously lower alkyl.
где R выбирают из группы, состоящей из замещенного и незамещенного бензила формулы
где Q и Q' независимо выбирают из группы, состоящей из водорода, низшего алкила, трифторметила, нитро, диалкиламина, циана и циклоалкил - низшего алкила с 3-6 кольцевыми атомами углерода, и R' - замещенный и незамещенный бензил, как определено выше.19. The compound according to 14 of formula (V)
where R is selected from the group consisting of substituted and unsubstituted benzyl of the formula
where Q and Q 'are independently selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, nitro, dialkylamine, cyan and cycloalkyl - lower alkyl with 3-6 ring carbon atoms, and R' is substituted and unsubstituted benzyl, as defined above.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/893,464 | 1997-07-11 | ||
US08/893,464 US5869669A (en) | 1996-07-26 | 1997-07-11 | Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000100062A true RU2000100062A (en) | 2001-09-10 |
RU2183636C2 RU2183636C2 (en) | 2002-06-20 |
Family
ID=25401603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000100062/04A RU2183636C2 (en) | 1997-07-11 | 1998-07-10 | Methods of synthesis of 14- hydroxynormorphinones, intermediate compounds |
Country Status (20)
Country | Link |
---|---|
US (7) | US5869669A (en) |
EP (1) | EP1000065B1 (en) |
JP (1) | JP2001518444A (en) |
KR (1) | KR100363486B1 (en) |
CN (1) | CN1152880C (en) |
AT (1) | ATE291023T1 (en) |
AU (1) | AU740822B2 (en) |
CA (1) | CA2296035C (en) |
DE (1) | DE69829379D1 (en) |
HK (1) | HK1028025A1 (en) |
HU (1) | HUP0003918A3 (en) |
IL (1) | IL133792A0 (en) |
IN (1) | IN1998KO01500A (en) |
NO (1) | NO20000111L (en) |
RU (1) | RU2183636C2 (en) |
SK (1) | SK102000A3 (en) |
TR (1) | TR200000033T2 (en) |
TW (1) | TW505648B (en) |
WO (1) | WO1999002529A1 (en) |
ZA (1) | ZA986144B (en) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5912347A (en) * | 1996-09-30 | 1999-06-15 | Mallinckrodt Inc. | Process for preparing a morphinan derivative |
AU4823900A (en) * | 1999-05-05 | 2000-11-17 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Direct c-14 oxidation of opioids |
US6177567B1 (en) | 1999-10-15 | 2001-01-23 | Boehringer Ingelheim Chemicals, Inc. | Method for preparing oxycodone |
MXPA04001647A (en) * | 2001-08-23 | 2004-05-31 | Akzo Nobel Nv | Process for the preparation of a 14-hydroxynormorphinone derivative. |
JP3961796B2 (en) * | 2001-08-27 | 2007-08-22 | ソニー株式会社 | Information providing system, information processing apparatus and method, information providing apparatus and method, recording medium, and program |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
US20040058946A1 (en) * | 2002-07-05 | 2004-03-25 | Buchwald Stephen L. | Abuse-resistant prodrugs of oxycodone and other pharmaceuticals |
US7771707B2 (en) | 2004-06-12 | 2010-08-10 | Collegium Pharmaceutical, Inc. | Abuse-deterrent drug formulations |
EP1562953B1 (en) * | 2002-11-08 | 2009-09-30 | Mallinckrodt Inc. | Process for the preparation of quaternary n-alkyl morphinan alkaloid salts |
ES2350689T3 (en) * | 2002-12-13 | 2011-01-26 | Durect Corporation | ORAL DRUG SUPPLY SYSTEM THAT INCLUDES HIGH VISCOSITY LIQUID VEHICLE MATERIALS. |
US6864370B1 (en) * | 2003-06-05 | 2005-03-08 | Zhaiwei Lin | Process for manufacturing oxycodone |
US6790959B1 (en) | 2003-06-05 | 2004-09-14 | Halsey Drug Company, Inc. | Process for manufacturing thebaine |
EP1664061B1 (en) | 2003-09-22 | 2017-03-15 | GlaxoSmithKline Australia Pty Ltd | Process for the synthesis of morphinane compounds and intermediates thereof |
US7875718B2 (en) * | 2003-09-22 | 2011-01-25 | Johnson Matthey Public Limited Company | Process for the synthesis of morphinane compounds and intermediates thereof |
WO2005077957A2 (en) | 2004-02-06 | 2005-08-25 | Euro-Celtique S.A. | Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates |
TW201509943A (en) * | 2004-03-30 | 2015-03-16 | Euro Celtique Sa | Oxycodone hydrochloride composition, pharmaceutical dosage form, sustained release oral dosage form and pharmaceutically acceptable package having less than 25 PPM 14-hydroxycodeinone |
SK286047B6 (en) * | 2004-04-13 | 2008-01-07 | Zentiva, A. S. | Method for the preparation of 4,5alpha-epoxy-6-oxomorphinane derivatives |
US6946556B1 (en) * | 2004-05-21 | 2005-09-20 | Acura Pharmaceuticals, Inc. | Preparation of opioid analgesics by a one-pot process |
JP2008501797A (en) * | 2004-06-08 | 2008-01-24 | マリンクロッド・インコーポレイテッド | Extraction of alkaloids from opium |
KR101492361B1 (en) | 2004-09-17 | 2015-02-11 | 듀렉트 코퍼레이션 | Sustained local anesthetic composition containing preferably a sugar ester such as SAIB |
GB0421149D0 (en) * | 2004-09-23 | 2004-10-27 | Johnson Matthey Plc | Preparation of oxycodone |
GB0421687D0 (en) * | 2004-09-30 | 2004-11-03 | Johnson Matthey Plc | Preparation of opiate analgesics |
WO2006084389A1 (en) * | 2005-02-11 | 2006-08-17 | Cilag Ltd. | Method for purifying noroxymorphone compounds |
PT1861405E (en) * | 2005-03-04 | 2009-07-27 | Euro Celtique Sa | Method of reducing alpha, beta- unsaturated ketones in opioid compositions |
US8071768B2 (en) * | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
CA2610859C (en) * | 2005-06-16 | 2013-11-12 | Peter Xianqi Wang | A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
US20070117826A1 (en) * | 2005-11-23 | 2007-05-24 | Forest Laboratories, Inc. | Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone |
DE602007003197D1 (en) | 2006-03-02 | 2009-12-24 | Mallinckrodt Inc | PROCESS FOR PREPARING MORPHINAN 6-ON PRODUCTS WITH LOW CONCENTRATIONS OF ALPHA, BETA-UNSATURATED KETONE COMPOUNDS |
SA07280459B1 (en) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic |
EP2099764B1 (en) * | 2006-09-20 | 2011-07-27 | Mallinckrodt Inc. | Preparation of substituted morphinan-6-ones and salts and intermediates thereof |
US20080125592A1 (en) * | 2006-10-17 | 2008-05-29 | Penick Corporation | Process for preparing oxymorphone, naltrexone, and buprenorphine |
CA2674915C (en) * | 2006-10-17 | 2015-06-30 | Penick Corporation | Process for preparing oxymorphone |
WO2008048711A1 (en) * | 2006-10-17 | 2008-04-24 | Penick Corporation | Process for preparing oxymorphone |
AU2012216358B2 (en) * | 2006-10-17 | 2014-11-20 | Penick Corporation | Process For Preparing Oxymorphone, Naltrexone and Buprenorphine |
AU2007325918B2 (en) | 2006-11-03 | 2013-10-17 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
CN101652370A (en) * | 2006-12-04 | 2010-02-17 | 诺拉姆科有限公司 | The method of the oxycodone that preparation 14-hydroxycodeine ketone level reduces |
ATE543823T1 (en) * | 2006-12-04 | 2012-02-15 | Noramco Inc | METHOD FOR REDUCING IMPURITIES IN OXYCODONE BASE |
GB0624880D0 (en) * | 2006-12-14 | 2007-01-24 | Johnson Matthey Plc | Improved method for making analgesics |
US9040726B2 (en) * | 2007-03-06 | 2015-05-26 | Mallinckrodt Llc | Process for the preparation of quaternary N-alkyl morphinan alkaloid salts |
WO2008109156A2 (en) * | 2007-03-06 | 2008-09-12 | Mallinckrodt Inc. | Process for the preparation of quaternary n-alkyl morphinan alkaloid salts |
AU2008231127B2 (en) * | 2007-03-23 | 2013-05-02 | SpecGx LLC | Improved preparation of oxymorphone from oripavine |
ES2423180T3 (en) * | 2007-04-16 | 2013-09-18 | Mallinckrodt Llc | New opioid reduction by catalytic hydrogen transfer reaction |
WO2008144320A2 (en) * | 2007-05-17 | 2008-11-27 | Endo Pharmaceuticals, Inc. | Opioid and methods of making and using the same |
JP2011506318A (en) | 2007-12-06 | 2011-03-03 | デュレクト コーポレーション | Oral pharmaceutical formulation |
CN101896464B (en) * | 2007-12-17 | 2014-12-10 | 马林克罗特有限公司 | Sinomenine derivatives and processes for their synthesis |
ES2569655T3 (en) * | 2007-12-17 | 2016-05-12 | Mallinckrodt Llc | Procedures for the production of (+) - 'nal' morphinan compounds |
EP2250175B1 (en) | 2008-02-29 | 2011-08-10 | Mallinckrodt Inc. | Process for the preparation of 3-hydroxymorphinan derivatives |
PT2291380E (en) * | 2008-04-24 | 2011-12-22 | Janssen Pharmaceutica Nv | Nalmefene prodrugs |
US8148528B2 (en) * | 2008-05-27 | 2012-04-03 | Mallinckrodt Llc | Processes and compounds for the preparation of normorphinans |
US9458109B2 (en) | 2008-09-03 | 2016-10-04 | Mallinckrodt Llc | Substituted berbines and processes for their synthesis |
US8080661B2 (en) * | 2008-09-30 | 2011-12-20 | Mallinckrodt Llc | Processes for the synthesis of tertiary amines |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
UA102916C2 (en) | 2009-07-02 | 2013-08-27 | Кемфарм, Інк. | Composition based on conjugates of hydrocodone with benzoic acid, benzoic acid or heteroaryl carboxylic acid derivatives, prodrugs and method for treatment of abuses |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
AU2011263416B2 (en) | 2010-06-11 | 2014-04-10 | Rhodes Technologies | Process for N-dealkylation of tertiary amines |
ES2666404T3 (en) | 2010-06-11 | 2018-05-04 | Rhodes Technologies | Transition metal catalyzed processes for the preparation and use of N-allyl compounds |
US8703950B2 (en) | 2010-07-02 | 2014-04-22 | Johnson Matthey Public Limited Co. | Low ABUK oxycodone, its salts and methods of making same |
RU2448709C1 (en) * | 2011-02-01 | 2012-04-27 | Учреждение Российской академии наук Институт проблем химико-энергетических технологий Сибирского отделения РАН (ИПХЭТ СО РАН) | Method for making naltrexone |
TWI560170B (en) * | 2011-12-06 | 2016-12-01 | Lundbeck & Co As H | Process for recovery of nalmefene hydrochloride |
US9315514B2 (en) | 2012-08-27 | 2016-04-19 | Rhodes Technologies | 1,3-dioxanomorphides and 1,3-dioxanocodides |
CA2894967A1 (en) | 2012-12-14 | 2014-06-19 | Purdue Pharma L.P. | Spirocyclic morphinans and their use |
TWI513697B (en) | 2012-12-14 | 2015-12-21 | Purdue Pharma Lp | Pyridonemorphinan analogs and biological activity on opioid receptors |
JP6163210B2 (en) | 2012-12-14 | 2017-07-12 | パーデュー、ファーマ、リミテッド、パートナーシップ | Nitrogen-containing morphinan derivatives and uses thereof |
US8957084B2 (en) | 2012-12-28 | 2015-02-17 | Purdue Pharma L.P. | 7,8-cyclicmorphinan analogs |
JP6159417B2 (en) | 2012-12-28 | 2017-07-05 | パーデュー、ファーマ、リミテッド、パートナーシップ | Substituted morphinans and uses thereof |
AU2013369037C1 (en) | 2012-12-31 | 2017-06-08 | Rhodes Technologies | Process for preparing 7beta-substituted 6alpha,14alpha -ethenomorphinans and 7beta-substituted 6alpha,14alpha-ethanomorphinans |
WO2014144975A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
EP2829541A1 (en) * | 2013-07-26 | 2015-01-28 | Siegfried AG | Novel synthesis of noroxymorphone from morphine |
RU2637934C2 (en) | 2013-08-02 | 2017-12-08 | Джонсон Мэтти Паблик Лимитед Компани | Method of producing oximorphon |
WO2015097546A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | Propellane-based compounds and their use as opioid receptor modulators |
WO2015097547A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | 10-substituted morphinan hydantoins |
EP3087079B1 (en) | 2013-12-26 | 2019-04-03 | Purdue Pharma LP | Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans |
WO2015097548A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | 7-beta-alkyl analogs of orvinols |
EP3089978B1 (en) | 2013-12-30 | 2018-08-29 | Purdue Pharma L.P. | Pyridone-sulfone morphinan analogs as opioid receptor ligands |
KR20190049944A (en) * | 2014-11-25 | 2019-05-09 | 켐팜 인코포레이티드 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone |
EP3252055B1 (en) | 2016-05-31 | 2018-09-19 | Alcaliber Investigacion Desarrollo e Innovacion SLU | Process for obtaining 3,14-diacetyloxymorphone from oripavine |
US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
WO2018116281A1 (en) | 2016-12-23 | 2018-06-28 | Minoryx Therapeutics S.L. | Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof |
SK592017A3 (en) | 2017-07-04 | 2019-01-08 | Saneca Pharmaceuticals A. S. | Method for preparing morphinan compounds |
CA3091826A1 (en) | 2018-02-23 | 2019-08-29 | Rhodes Technologies | Novel opioid compounds and uses thereof |
CN110054656B (en) * | 2019-05-28 | 2021-02-02 | 宜昌人福药业有限责任公司 | Synthesis method of 10-carbonyl/hydroxymorphine-6-glucuronide |
WO2021007366A1 (en) * | 2019-07-08 | 2021-01-14 | St. Louis College Of Pharmacy | G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment |
BR112022013784A2 (en) | 2020-01-13 | 2022-10-11 | Durect Corp | DISTRIBUTION SYSTEMS FOR PROLONGED RELEASE DRUGS WITH REDUCED IMPURITIES AND RELATED METHODS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3819636A (en) * | 1970-09-15 | 1974-06-25 | American Home Prod | 4a,10-(methaniminomethano)phenanthrene derivatives |
US4795813A (en) * | 1981-08-17 | 1989-01-03 | The Florida Board Of Regents On Behalf Of The Florida State University | Synthesis of derivatives of codeine and other 3-O-alkylmorphines |
US5112975A (en) * | 1984-03-27 | 1992-05-12 | Mallinckrodt Specialty Chemicals Company | Preparation of noroxymorphone from morphine |
US4668685A (en) * | 1984-07-05 | 1987-05-26 | E.I. Du Pont De Nemours And Company | Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists |
US4912114A (en) * | 1988-03-18 | 1990-03-27 | Sandoz Ltd. | Morphinan derivatives |
-
1997
- 1997-07-11 US US08/893,464 patent/US5869669A/en not_active Expired - Fee Related
-
1998
- 1998-07-10 TR TR2000/00033T patent/TR200000033T2/en unknown
- 1998-07-10 RU RU2000100062/04A patent/RU2183636C2/en not_active IP Right Cessation
- 1998-07-10 HU HU0003918A patent/HUP0003918A3/en unknown
- 1998-07-10 IL IL13379298A patent/IL133792A0/en unknown
- 1998-07-10 EP EP98934213A patent/EP1000065B1/en not_active Revoked
- 1998-07-10 WO PCT/US1998/013592 patent/WO1999002529A1/en not_active Application Discontinuation
- 1998-07-10 KR KR20007000252A patent/KR100363486B1/en not_active IP Right Cessation
- 1998-07-10 DE DE69829379T patent/DE69829379D1/en not_active Expired - Lifetime
- 1998-07-10 SK SK10-2000A patent/SK102000A3/en unknown
- 1998-07-10 JP JP2000502051A patent/JP2001518444A/en active Pending
- 1998-07-10 AU AU83791/98A patent/AU740822B2/en not_active Ceased
- 1998-07-10 AT AT98934213T patent/ATE291023T1/en not_active IP Right Cessation
- 1998-07-10 CN CNB988088169A patent/CN1152880C/en not_active Expired - Fee Related
- 1998-07-10 ZA ZA986144A patent/ZA986144B/en unknown
- 1998-07-10 CA CA002296035A patent/CA2296035C/en not_active Expired - Fee Related
- 1998-07-16 US US09/116,283 patent/US6008355A/en not_active Expired - Fee Related
- 1998-07-16 US US09/116,284 patent/US5922876A/en not_active Expired - Fee Related
- 1998-07-16 US US09/116,286 patent/US5952495A/en not_active Expired - Fee Related
- 1998-07-16 US US09/116,285 patent/US6008354A/en not_active Expired - Fee Related
- 1998-07-16 US US09/116,282 patent/US6013796A/en not_active Expired - Fee Related
- 1998-07-17 US US09/118,577 patent/US5948788A/en not_active Expired - Fee Related
- 1998-08-21 IN IN1500KO1998 patent/IN1998KO01500A/en unknown
- 1998-09-29 TW TW087116132A patent/TW505648B/en not_active IP Right Cessation
-
2000
- 2000-01-10 NO NO20000111A patent/NO20000111L/en not_active Application Discontinuation
- 2000-11-15 HK HK00107260A patent/HK1028025A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2000100062A (en) | METHOD OF OBTAINING 14-HYDROXYNORMORPHINONES AND OXYCODON, NOROXYMORPHONE AND NALTREXONE FROM NORMORPHINONES | |
RU2183636C2 (en) | Methods of synthesis of 14- hydroxynormorphinones, intermediate compounds | |
BR9200208A (en) | PROCESS FOR CARBONILATION OF ONE OR MORE COMPOUNDS IN THE GROUP CONSISTING OF METHANOL, DIMETHYL ETER, OR METHYL ACETATE FOR ACETIC ACID | |
BR0211899B1 (en) | PROCESSES FOR THE PREPARATION OF A 14- HYDROXINORMORPHINONE DERIVATIVE AND FOR THE PRODUCTION OF NOROXYMORPHONE | |
EP0925065A4 (en) | Water miscible erythromycin solutions | |
ATE45358T1 (en) | PREPARATION OF 14-HYDROXY-N-ETHOXYCARBONYLNORCODEINONE. | |
Michne et al. | Analgesic 1-oxidized-2, 6-methano-3-benzazocines | |
KR890016044A (en) | Method for preparing indole-3-carboxylic acid ester of trans-hexahydro-8-hydroxy-2,6-methano-2H-quinolizine-3 (4H) -one | |
WO2007102352A3 (en) | Process for preparing dibenzothiazepine compounds | |
DE57631T1 (en) | ((INDOL-3-YL) -3-AMINO-2-PROPIONYLOXY) -2-ACETIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING IT. | |
DE69926642D1 (en) | PROCESS FOR THE PREPARATION OF N-PROTECTED AZETIDINE-2-CARBOXYLIC ACIDS | |
JPS5511048A (en) | Cellulose acetate base reverse osmosis membrane treating agent | |
JPS5419964A (en) | Preparation of thiophene-substituted fatty acid halode | |
KR927003535A (en) | Method for Purifying 7-chloroquinoline-8-carboxylic Acid | |
RU95122160A (en) | METHOD OF OBTAINING NG-MONOALKYL-L-ARGININE AND RELATED COMPOUNDS | |
KR850006428A (en) | Method for preparing erythromycin acetate | |
CA2069352A1 (en) | Method of preparing .alpha.-l-aspartyl-l-phenylalaline methyl ester hydrochloride | |
JPS52116433A (en) | Preparation of benzanilide derivatives | |
ATE266624T1 (en) | METHOD FOR PRODUCING L-VALINEBENZYLESTER-P-TOLUENE SUFONATES | |
JPS57120553A (en) | Preparation of aromatic amine compound | |
ATE1502T1 (en) | 7-METHYL AND 7-METHYL-8-LOWER ALKYL B/C CIS OR TRANS MORPHINAN-6-ONE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM. | |
JPS51125309A (en) | Process for preparation of glycerine | |
JPS57185284A (en) | 7-deazapurine derivative and its preparation | |
CA2359080A1 (en) | Method for reducing 3-dimethylamino-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester | |
JPS51143025A (en) | Improved temporary coloring agent solution |